EP3215158
APILIMOD FOR USE IN THE TREATMENT OF RENAL CANCER
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
6.11.2015EP published:
8.5.2019EP application number:
15795318.3
EPO information:
European Patent Register
Max expiry date:
5.11.2035
Title:
APILIMOD FOR USE IN THE TREATMENT OF RENAL CANCER
Timeline
Today
6.11.2015EP application
8.5.2019EP Publication
Owner
Name:
AI Therapeutics, Inc.Address:
530 Old Whitfield Street, 06437, Guilford, CT, US
Inventor
Name:
BEEHARRY, NeilAddress:
Guilford, CT, US
Name:
GAYLE, SophiaAddress:
Guilford, CT, US
Name:
LANDRETTE, SeanAddress:
Guilford, CT, US
Name:
BECKETT, PaulAddress:
Guilford, CT, US
Name:
CONRAD, ChrisAddress:
Guilford, CT, US
Name:
XU, TianAddress:
Guilford, CT, US
Name:
ROTHBERG, Jonathan, M.Address:
Guilford, CT, US
Name:
LICHENSTEIN, HenriAddress:
Guilford, CT, US
Priority
Number:
201462077127 PDate:
7.11.2014Country:
US
Classification
Categories:
A61K 31/5377, A61K 45/06, A61P 35/00, A61K 31/44, A61K 31/506